SCHEMBL10506484

SCHEMBL10506484

CC(CCCCCCCCC(O)CC(=O)O)C1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 4/20 0.53
▸ ALDH1A1 P00352 2/20 0.42
▸ FFAR4 Q5NUL3 1/20 0.37
▸ FFAR1 O14842 1/20 0.37
▸ SLC22A6 Q4U2R8 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HMGCR P04035 1/20 0.33
▸ ACACB O00763 1/20 0.33
▸ ACACA Q13085 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CPB2 Q96IY4 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ GABRR1 P24046 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764588 0.81 TSHR (0.40) GPR84ALDH1A1KMT2ATSHR
SCHEMBL9764526 0.80 GPR84 (0.33) GPR84ALDH1A1FFAR4FFAR1KMT2A
Bicarbonate SCHEMBL28611463 0.79 EPHX1 (0.44) GPR84FFAR1TSHR
Bicarbonate SCHEMBL28454760 0.79 EPHX1 (0.44) GPR84FFAR1TSHR
SCHEMBL2180615 0.78 ALDH1A1 (0.46) ALDH1A1MAPTTSHRHIF1AHSD17B10
SCHEMBL27587755 0.78 GPR84 (0.66) GPR84ALDH1A1FFAR4FFAR1KMT2A
SCHEMBL1208925 0.77 ALDH1A1 (0.55) ALDH1A1
SCHEMBL6808670 0.77 ALDH1A1 (0.55) ALDH1A1
SCHEMBL8651989 0.77 ALDH1A1 (0.55) ALDH1A1
SCHEMBL4362453 0.76 ALDH1A1 (0.43) ALDH1A1SLC22A6MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0194610-B1 SUBSTITUTED GLUTARIC ACID LACTONES IN THE TREATMENT OF HYPERLIPIDEMIA G.D. Searle & Co. (US) 1989-02-22 — — EP disclosed
EP-0194610-A1 Substituted glutaric acid lactones in the treatment of hyperlipidemia G.D. Searle & Co. (US) 1986-09-17 — — EP disclosed
Send feedback